Home › Ventricular Tachycardia › NCT07777744
Severe Complications During Ventricular Tachycardia or Premature Ventricular Complex Ablation
Severe Complications During Ventricular Tachycardia or Premature Ventricular Complex Ablation - an International Multicenter Collaborative Study Group
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Centers : Centers participating in the present collaborative study group. Invitation to participate will be based either upon personal referral of one of the investigator, previous collaboration or based on a meta-analytic review of the literature published on the subject within the past 20 years. * Patients: Females and males of \>18 years undergoing any type of VT/PVC ablation. While we will accept redo-procedure we will ask for a unique patient-identifier to link procedures belonging to the same patients together. * Interventions: VT/PVC ablation (first intervention or re-do) as routinely performed by the participating centers * Outcomes: Severe complications, defined as hemodynamic instability requiring mechanical intensive-care management, tamponade, stroke, cardiac arrest, myocardial infarction, phrenic nerve palsies, major bleeding requiring transfusion, vascular or cardiac complication requiring surgery, procedure-related death. * Setting: Observational cohort studies, registries, retrospective cohort studies. Data stemming from RCTs (Randomized controlled trials) will not be collected as they likely do not represent a "real-life" setting. * Length of follow-up: Peri-procedural complications * Years considered: Not limited to a specific time-frame, but to reflect common ablation practices, we will focus on data from the 20 past years. * Number of patients provided : No lower limit of patients provided per dataset or ablation volume per year to include high- as well as low-volume centers Exclusion Criteria: * Refusal of the center to participate. * Less than 10 procedures available in the dataset (no case reports) * Missing essential baseline characteristics, missing collection of sufficient details regarding each complication.
About the study
The investigators aim to characterize patients presenting with a severe ventricular tachycardia (VT) and premature ventricular complex (PVC)-ablation-related complication including patient characteristics, procedural details and subsequent management of the complication by gathering existing patient-level data.
Sponsor: University Hospital, Basel, Switzerland · Participants: 15,000 · Started: Jul 1, 2024
Contact the study team
- Michael Kühne, Prof. Dr. med. · Phone: 0041 61 265 52 14
Official record on ClinicalTrials.gov — NCT07777744
Locations in the U.S.
| Illinois | Rush University Medical Center, Chicago |
| Michigan | University of Michigan, Michigan Center |
Conditions
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.